Technical Analysis – EURJPY gains traction after push above 200-day SMA



EURJPY has found some positive footing at 129.61, which happens to be a level of confluence and the 50.0% Fibonacci retracement of the up leg from 125.08 until 134.12. Positive factors that may contribute to reviving upside momentum are the persistent backing of the positive structure by the 100- and 200-day simple moving averages (SMAs), together with the easing in the 50-day SMA's negative bearing.

The short-term oscillators are also suggesting a growing bullish drive. The MACD has nudged a tad above its red trigger line, while the RSI has rebounded off the 50 threshold and is improving in the bullish region. The stochastic oscillator is also promoting additional gains in the pair.

If the current price trajectory persists, buyers may face a primary resistance zone between the 38.2% Fibo of 130.66 and the 100-day SMA at 131.00. Surpassing the upper Bollinger band and the 131.00 hurdle could propel the pair towards the 23.6% Fibo at 132.00 ahead of the 132.42-132.69 barricade overhead. In the event buyers manage to acquire even more ground, they may then challenge the near 40-month region of peaks between 133.57 and 134.12.

To the downside, sellers will need to initially drive the price beneath the 50.0% Fibo of 129.61, simultaneously breaching the 50- and 200-day SMAs as well as the mid-Bollinger band, which are converging at this level. Moving down from this critical mark, sellers could then meet the 61.8% Fibo of 128.52 prior to testing the lower Bollinger band at 128.20 and the adjacent trough of 127.92. Resuming the decline, the pair may hit the 76.4% Fibo of 127.24 before the 126.09 low comes into play.

Summarizing, EURJPY is sustaining a neutral-to-bullish tone in the medium-term as the price holds above the 50.0% Fibo of 129.61 and the 200-day SMA. In the short-term picture a stronger price move could evolve with a break either below 127.92 or above 131.00.

 

 

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.